Margaret G. McGlynn, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), bought 1,000 shares at $45.50 ($46K) on 2012-11-07, disclosed to the SEC on 2012-11-08.
Open-market purchase of $46k VRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| FOLD | SELL | 2022-05-04 | $105K | — | Filing → |
| VRTX | SELL | 2022-04-12 | $1.4M | — | Filing → |
| VRTX | SELL | 2022-04-04 | $2.6M | — | Filing → |